We can’t show the full text here under this license. Use the link below to read it at the source.
Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine
New psychedelic treatments for post-traumatic stress disorder and their potential for personalized care
AI simplified
Abstract
Psychedelic compounds such as ketamine, MDMA, and psilocybin may enhance treatment for post-traumatic stress disorder (PTSD).
- may modulate pathways related to synaptic plasticity, potentially improving memory processing and extinction.
- Combining psychedelics with existing treatments could enhance the efficacy of current psychotherapies for PTSD.
- Rapid and lasting improvements in chronic symptoms may be achievable with these novel interventions.
- Modern prediction methods for treatment response could allow for personalized psychedelic interventions tailored to individual patients.
- This review identifies limitations in current PTSD treatment and explores the potential of psychedelics and .
AI simplified